eFFECTOR Therapeutics, Inc.
NASDAQ:EFTR
0.04 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 14.875 | 8.708 | 49.702 | 15.216 | 3.427 |
| Short Term Investments
| 3.495 | 17.602 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 18.37 | 26.31 | 49.702 | 15.216 | 3.427 |
| Net Receivables
| 0.052 | 0.027 | 0.1 | 0 | 0 |
| Inventory
| 0 | -0.027 | -0.1 | 0 | 0 |
| Other Current Assets
| 1.416 | 1.704 | 3.194 | 1.362 | 0.845 |
| Total Current Assets
| 19.838 | 28.014 | 52.896 | 16.578 | 4.272 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 0.193 | 0.352 | 0.257 | 0.126 | 0.823 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.513 | 0.711 | 0.903 | -0.126 | -0.823 |
| Total Non-Current Assets
| 0.706 | 1.063 | 1.16 | 0.126 | 0.823 |
| Total Assets
| 20.544 | 29.077 | 54.056 | 16.704 | 5.095 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 2.33 | 1.486 | 0.516 | 0.347 | 0.598 |
| Short Term Debt
| 19.445 | 20.221 | 0.044 | 6.015 | 15.245 |
| Tax Payables
| 0 | 0.463 | 0.351 | 0.351 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 1.984 | 0 |
| Other Current Liabilities
| 4.021 | 3.368 | 3.418 | 0.433 | 3.091 |
| Total Current Liabilities
| 25.796 | 25.075 | 3.978 | 8.779 | 18.934 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 0 | 0.06 | 19.986 | 6.946 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.543 | 0.046 | 12.808 | 133.224 | 0 |
| Total Non-Current Liabilities
| 0.543 | 0.106 | 32.794 | 140.17 | 0 |
| Total Liabilities
| 26.339 | 25.181 | 36.772 | 148.949 | 18.934 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 54.056 | 133.224 | 133.224 |
| Common Stock
| 0 | 0.004 | 0.004 | 0.001 | 0.001 |
| Retained Earnings
| -179.377 | -143.566 | -120.901 | -136.699 | -150.91 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.018 | -54.056 | -133.225 | -0.001 |
| Other Total Stockholders Equity
| 173.582 | 147.476 | 138.181 | 4.454 | 3.847 |
| Total Shareholders Equity
| -5.795 | 3.896 | 17.284 | -132.245 | -13.839 |
| Total Equity
| -5.795 | 3.896 | 17.284 | -132.245 | -13.839 |
| Total Liabilities & Shareholders Equity
| 20.544 | 29.077 | 54.056 | 16.704 | 5.095 |